Case number 1:22-cv-01232
Zogenix, Inc. et al v. Apotex Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 3, 2023 | 69 | ORAL ORDER re 65 Unopposed Motion to Seal June 16, 2023 Report and Recommendations: The Court having reviewed the unopposed motion to seal and the associated filings (D.I. 65; D.I. 66; D.I. 67), IT IS ORDERED that the motion is GRANTED. Apotex has shown that disclosing the substantive contents of the proposed ANDA label and FDA communications regarding the label would cause a clearly defined and serious injury to Apotex due to the risk that competitors could use the details of Apotex's regulatory strategy for its ANDA product "as a roadmap for their own potential products[.]" Kaleo, Inc. v. Adamis Pharms. Corp., C.A. No. 19-917-RGA, 2019 WL 11680196, at *1 (D. Del. July 16, 2019); (D.I. 66 at ¶ 5). Ordered by Judge Sherry R. Fallon on 7/3/2023. (lih) (Entered: 07/03/2023) (0) |
| Jun 26, 2023 | 68 | ORAL ORDER: The Unopposed Motion to Seal June 16, 2023, Report and Recommendations (D.I. 65 in 22-cv-1232-RGA; D.I. 157 in 21-cv-1252-RGA) is now REFERRED to Magistrate Judge Sherry R. Fallon. Ordered by Judge Richard G. Andrews on 6/26/2023. Motions referred to Sherry R. Fallon.Associated Cases: 1:21-cv-01252-RGA, 1:22-cv-01232-RGA(nms) (Entered: 06/26/2023) (0) |
| Jun 23, 2023 | 67 | REDACTED VERSION of 64 Report and Recommendations, by Apotex Corp., Apotex Inc.. (Hitch, Cortlan) Modified on 6/23/2023 (nms). (Entered: 06/23/2023) (24) |
| Jun 23, 2023 | 66 | DECLARATION re 65 Unopposed Motion to Seal June 16, 2023 Report and Recommendation, by Apotex Corp., Apotex Inc.. (Hitch, Cortlan) Modified on 6/23/2023 (nms). (Entered: 06/23/2023) (4) |
| Jun 23, 2023 | 65 | Unopposed Motion to Seal June 16, 2023 Report and Recommendation - filed by Apotex Corp., Apotex Inc.. (Hitch, Cortlan) Modified on 6/23/2023 (nms). (Entered: 06/23/2023) (8) |
| Jun 16, 2023 | 64 | [SEALED] REPORT AND RECOMMENDATIONS- re (14 in 1:22-cv-01232-RGA) MOTION to Dismiss, (95 in 1:21-cv-01252-RGA) MOTION for Leave to File Amended Complaint. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 6/30/2023. Signed by Judge Sherry R. Fallon on 6/16/2023.This order has been emailed to local counsel. Associated Cases: 1:21-cv-01252-RGA, 1:22-cv-01232-RGA(lih) (Entered: 06/16/2023) (0) |
| Apr 14, 2023 | 63 | ORAL ORDER- The court shall hear argument re (95 in 1:21-cv-01252-RGA) MOTION for Leave to File Amended Complaint and (14 in 1:22-cv-01232-RGA) MOTION to Dismiss on 6/13/2023 at 10:00 AM in Courtroom 6C before Judge Sherry R. Fallon. Counsel shall collectively have one hour for argument. Any slide presentations the parties plan on using during the hearing should be emailed (in PDF format) to Rebecca Polito at Rebecca_Polito@ded.uscourts.gov by no later than 10:00 AM on 6/12/2023. The Court may choose to resolve the motions prior to the hearing and will, in that event, cancel the hearing. Ordered by Judge Sherry R. Fallon on 4/14/2023. Associated Cases: 1:22-cv-01232-RGA, 1:21-cv-01252-RGA(lih) (Entered: 04/14/2023) (0) |
| Apr 5, 2023 | 62 | ORAL ORDER: The Motion to Dismiss Pursuant to F.R.C.P 12(b)(1) and 12(b)(6) (D.I. 14 ) is now REFERRED to Magistrate Judge Sherry R. Fallon. Ordered by Judge Richard G. Andrews on 4/5/2023. *Motions referred to Sherry R. Fallon.(nms) (Entered: 04/05/2023) (0) |
| Mar 15, 2023 | 61 | NOTICE OF SERVICE of (1) Plaintiffs' First Set of Request for Admission to Apotex Inc. and Apotex Corp. (Nos. 1-51); (2) Plaintiffs' Second Set of Interrogatories (Nos. 11-20); (3) Plaintiffs' Amended and Supplemental Infringement Claim Charts; and (4) Plaintiffs' Supplemental Responses and Objections to Defendants' Interrogatory No. 3 filed by Zogenix International Ltd., Zogenix, Inc., Katholieke Universiteit Leuven, University Hospital Antwerp.(Dellinger, Megan) (Entered: 03/15/2023) (3) |
| Mar 15, 2023 | 60 | NOTICE OF SERVICE of (1) Plaintiffs' First Set of Request for Admission to Lupin Ltd. (Nos. 1-43); (2) Plaintiffs' Second Set of Interrogatories (Nos. 11-18); (3) Plaintiffs' Amended and Supplemental Infringement Claim Charts; and (4) Plaintiffs' Supplemental Responses and Objections to Defendants' Interrogatory No. 3 filed by Zogenix International Ltd., Zogenix, Inc., Katholieke Universiteit Leuven, University Hospital Antwerp.(Dellinger, Megan) (Entered: 03/15/2023) (3) |
| Mar 15, 2023 | 59 | NOTICE OF SERVICE of Plaintiffs' Amended Identification of Asserted Claims filed by Zogenix International Ltd., Zogenix, Inc..(Dellinger, Megan) (Entered: 03/15/2023) (3) |
| Mar 15, 2023 | 58 | SO ORDERED Granting (D.I. 102 in 21-cv-1424-RGA; D.I. 57 in 22-cv-1232-RGA; D.I. 132 in 21-cv-1252-RGA) Stipulation to Consolidate Cases. Signed by Judge Richard G. Andrews on 3/15/2023. Associated Cases: 1:21-cv-01252-RGA, 1:21-cv-01424-RGA, 1:22-cv-01232-RGA(nms) (Entered: 03/15/2023) (3) |
| Mar 15, 2023 | 57 | STIPULATION to Consolidate Cases by Zogenix International Ltd., Zogenix, Inc., Katholieke Universiteit Leuven, University Hospital Antwerp. (Dellinger, Megan) (Entered: 03/15/2023) (3) |
| Mar 14, 2023 | 56 | ANSWER to 1 Complaint and COUNTERCLAIM against Zogenix International Ltd., Zogenix, Inc., by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) Modified on 3/15/2023 (nms). (Entered: 03/14/2023) (30) |
| Mar 10, 2023 | 52 | NOTICE to Take Deposition of Stephen Farr filed by Lupin Limited, Lupin Ltd..(Bilson, David) (Entered: 03/10/2023) (3) |
| Mar 10, 2023 | 55 | NOTICE to Take Deposition of Brooks Boyd filed by Lupin Limited, Lupin Ltd..(Bilson, David) (Entered: 03/10/2023) (3) |
| Mar 10, 2023 | 54 | NOTICE to Take Deposition of Derek Londesbrough filed by Lupin Limited, Lupin Ltd..(Bilson, David) (Entered: 03/10/2023) (3) |
| Mar 10, 2023 | 53 | NOTICE to Take Deposition of Marc Andersen filed by Lupin Limited, Lupin Ltd..(Bilson, David) (Entered: 03/10/2023) (3) |
| Mar 10, 2023 | 51 | NOTICE to Take Deposition of Ashish Sagrolikar filed by Lupin Limited, Lupin Ltd..(Bilson, David) (Entered: 03/10/2023) (3) |
| Mar 10, 2023 | 50 | NOTICE to Take Deposition of Lieven Lagae filed by Lupin Limited, Lupin Ltd..(Bilson, David) (Entered: 03/10/2023) (3) |
| Mar 10, 2023 | 49 | NOTICE to Take Deposition of Berten Ceulemens filed by Lupin Limited, Lupin Ltd..(Bilson, David) (Entered: 03/10/2023) (3) |
| Mar 10, 2023 | 48 | NOTICE OF SERVICE of (1) Paragraph 3 Disclosures; and (2) Rule 26(A)(1) Disclosures filed by Zogenix International Ltd., Zogenix, Inc..(Dellinger, Megan) (Entered: 03/10/2023) (4) |
| Mar 10, 2023 | 47 | NOTICE to Take Deposition of Plaintiffs Pursuant to Fed. R. Civ. P. 30(b)(6) (Joint Notice) filed by Lupin Limited, Lupin Ltd..(Bilson, David) (Entered: 03/10/2023) (17) |
| Mar 8, 2023 | 46 | MOTION for Pro Hac Vice Appearance of Attorney Luke T. Shannon - filed by Apotex Corp., Apotex Inc., Apotex Inc.. (Dorsney, Kenneth) (Entered: 03/08/2023) (3) |
| Mar 7, 2023 | 45 | NOTICE OF SERVICE of Plaintiffs' Identification of Asserted Claims filed by Zogenix International Ltd., Zogenix, Inc..(Dellinger, Megan) (Entered: 03/07/2023) (4) |
| Mar 1, 2023 | 44 | ORAL ORDER: The Stipulation to Consolidate and Stay Case (C.A. 21-1252-RGA, D.I. 112; C.A. 21-1424-RGA, D.I. 88; C.A. 22-1232, D.I. 43) is DENIED. The Court is not willing to stay the cases. The discovery deadlines in the two earlier cases (Nos. 21-1252 and 21-1424) will not be extended. The parties should proceed as though the motion for leave to amend (No. 21-1252, D.I. 95) will be granted and the motion to dismiss (No. 22-1232, D.I. 14) will be denied. Ordered by Judge Richard G. Andrews on 3/1/2023. Associated Cases: 1:21-cv-01252-RGA, 1:21-cv-01424-RGA, 1:22-cv-01232-RGA(nms) (Entered: 03/01/2023) (0) |
| Feb 22, 2023 | 43 | STIPULATION to Consolidate and Stay Case by Zogenix International Ltd., Zogenix, Inc., Katholieke Universiteit Leuven, University Hospital Antwerp. (Dellinger, Megan) (Entered: 02/22/2023) (4) |
| Jan 10, 2023 | 42 | ORAL ORDER: The redacted filing (D.I. 37 ) as supported by the Declaration (D.I. 38 ) is APPROVED. Ordered by Judge Richard G. Andrews on 1/10/2023. (nms) (Entered: 01/10/2023) (0) |
| Jan 9, 2023 | 41 | MOTION for Pro Hac Vice Appearance of Attorney Stephen R. Auten- filed by Apotex Inc.. (Dorsney, Kenneth) Modified on 1/9/2023 (nms). (Entered: 01/09/2023) (3) |
| Jan 9, 2023 | 40 | MOTION for Pro Hac Vice Appearance of Attorney Philip Y. Kouyoumdjian, Attorney Richard T. Ruzich, and Attorney Roshan P. Shrestha - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 01/09/2023) (5) |
| Dec 22, 2022 | 39 | REQUEST for Oral Argument by Zogenix International Ltd., Zogenix, Inc. re 14 MOTION to Dismiss Pursuant to F.R.C.P 12(b)(1) and 12(b)(6). (Dellinger, Megan) (Entered: 12/22/2022) (3) |
| Dec 21, 2022 | 37 | REDACTED VERSION of 16 Declaration of Roshan P. Shrestha, by Apotex Corp.. (Dorsney, Kenneth) Modified on 12/21/2022 (nms). (Entered: 12/21/2022) (30) |
| Dec 21, 2022 | 38 | DECLARATION of Olga Kalinina, Ph. D. re 37 Redacted Document, by Apotex Corp.. (Dorsney, Kenneth) Modified on 12/21/2022 (nms). (Entered: 12/21/2022) (3) |
| Dec 16, 2022 | 36 | REPLY BRIEF re 14 MOTION to Dismiss Pursuant to F.R.C.P 12(b)(1) and 12(b)(6) filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 12/16/2022) (16) |
| Dec 14, 2022 | 35 | ORAL ORDER: The Court appreciates the Declaration filed by Apotex. (D.I. 34 ). I think the Declaration would justify redactions of some of Exhibits B, C, and D. But the Declaration does not justify wholesale redaction of any of the three exhibits. Apotex is given one week to propose only the redactions necessary to protect the information identified by the Declarant. For example, in Exhibit B, why is anything other than the mentions [of] Apotexs strategy redacted? In Exhibit C, why are the parts that are just copied from Plaintiffs label redacted? Why are the instructions for how to give orally a medicine redacted?. Ordered by Judge Richard G. Andrews on 12/14/2022. (nms) (Entered: 12/14/2022) (0) |
| Dec 13, 2022 | 33 | REDACTED VERSION of 16 Declaration of Roshan P. Shrestha, by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) Modified on 12/13/2022 (nms). (Entered: 12/13/2022) (30) |
| Dec 13, 2022 | 34 | DECLARATION of Olga Kalinina, Ph. D. re 33 Redacted Document, by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) Modified on 12/13/2022 (nms). (Entered: 12/13/2022) (3) |
| Dec 12, 2022 | 32 | MOTION for Pro Hac Vice Appearance of Attorney Keith D. Parr, Nina Vachhani, Smitha B. Uthaman and Leah M. Brackensick - filed by Lupin Limited. (Attachments: # 1 Certification of Keith D. Parr, # 2 Certification of Nina Vachhani, # 3 Certification of Smitha B. Uthaman, # 4 Certification of Leah M. Brackensick)(Bilson, David) (Entered: 12/12/2022) (Certification of Leah M. Brackensick) (1) |
| Dec 12, 2022 | 32 | MOTION for Pro Hac Vice Appearance of Attorney Keith D. Parr, Nina Vachhani, Smitha B. Uthaman and Leah M. Brackensick - filed by Lupin Limited. (Attachments: # 1 Certification of Keith D. Parr, # 2 Certification of Nina Vachhani, # 3 Certification of Smitha B. Uthaman, # 4 Certification of Leah M. Brackensick)(Bilson, David) (Entered: 12/12/2022) (Main Document) (2) |
| Dec 12, 2022 | 32 | MOTION for Pro Hac Vice Appearance of Attorney Keith D. Parr, Nina Vachhani, Smitha B. Uthaman and Leah M. Brackensick - filed by Lupin Limited. (Attachments: # 1 Certification of Keith D. Parr, # 2 Certification of Nina Vachhani, # 3 Certification of Smitha B. Uthaman, # 4 Certification of Leah M. Brackensick)(Bilson, David) (Entered: 12/12/2022) (Certification of Smitha B. Uthaman) (1) |
| Dec 12, 2022 | 32 | MOTION for Pro Hac Vice Appearance of Attorney Keith D. Parr, Nina Vachhani, Smitha B. Uthaman and Leah M. Brackensick - filed by Lupin Limited. (Attachments: # 1 Certification of Keith D. Parr, # 2 Certification of Nina Vachhani, # 3 Certification of Smitha B. Uthaman, # 4 Certification of Leah M. Brackensick)(Bilson, David) (Entered: 12/12/2022) (Certification of Nina Vachhani) (1) |
| Dec 12, 2022 | 32 | MOTION for Pro Hac Vice Appearance of Attorney Keith D. Parr, Nina Vachhani, Smitha B. Uthaman and Leah M. Brackensick - filed by Lupin Limited. (Attachments: # 1 Certification of Keith D. Parr, # 2 Certification of Nina Vachhani, # 3 Certification of Smitha B. Uthaman, # 4 Certification of Leah M. Brackensick)(Bilson, David) (Entered: 12/12/2022) (Certification of Keith D. Parr) (1) |
| Dec 8, 2022 | 31 | STIPULATION and Proposed Order to Extend Time - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) Modified on 12/8/2022 (nms). (Entered: 12/08/2022) (2) |
| Dec 6, 2022 | 30 | ORAL ORDER: The Stipulation and Proposed Order for Leave to File Under Seal (D.I. 28 ) is GRANTED. The Court expects to wholly unseal the answering and reply briefs in due course. When the parties file their redacted versions, they shall send copies to the Case Manager with the redactions highlighted in yellow. Ordered by Judge Richard G. Andrews on 12/6/2022. (nms) (Entered: 12/06/2022) (0) |
| Dec 6, 2022 | 29 | ORDER RE: UNSEALING: The Brief (D.I. 15 ) is UNSEALED (see Order for further details). Signed by Judge Richard G. Andrews on 12/6/2022. (nms) (Entered: 12/06/2022) (3) |
| Dec 5, 2022 | 28 | STIPULATION and [Proposed] Order for Leave to File Under Seal by Zogenix International Ltd., Zogenix, Inc.. (Dellinger, Megan) (Entered: 12/05/2022) (2) |
| Dec 5, 2022 | 27 | ANSWERING BRIEF in Opposition re 14 MOTION to Dismiss Pursuant to F.R.C.P 12(b)(1) and 12(b)(6), filed by Zogenix International Ltd., Zogenix, Inc..Reply Brief due date per Local Rules is 12/12/2022. (Dellinger, Megan) Modified on 12/12/2022 (nms). (Entered: 12/05/2022) (26) |
| Nov 28, 2022 | 26 | MOTION for Pro Hac Vice Appearance of Attorney Justin W. Burnam - filed by Zogenix International Ltd., Zogenix, Inc.. (Dellinger, Megan) (Entered: 11/28/2022) (4) |
| Nov 28, 2022 | 25 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Lupin Limited. (Phillips, John) (Entered: 11/28/2022) (2) |
| Nov 28, 2022 | 24 | ANSWER to 1 Complaint and Affirmative Defenses, by Lupin Limited.(Phillips, John) Modified on 11/28/2022 (nms). (Entered: 11/28/2022) (30) |
| Nov 21, 2022 | 23 | DECLARATION of Roshan P. Shrestha re 21 Redacted Document, and 22 Redacted Document by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) Modified on 11/22/2022 (nms). (Entered: 11/21/2022) (2) |
| Nov 21, 2022 | 22 | REDACTED VERSION of 16 Declaration of Roshan P. Shrestha, by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) Modified on 11/22/2022 (nms). (Entered: 11/21/2022) (30) |
| Nov 21, 2022 | 21 | REDACTED VERSION of 15 Opening Brief in Support, by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) Modified on 11/22/2022 (nms). (Entered: 11/21/2022) (27) |
| Nov 21, 2022 | 20 | STIPULATION and Proposed Order to Extend Time - filed by Zogenix International Ltd., Zogenix, Inc.. (Dellinger, Megan) Modified on 11/21/2022 (nms). (Entered: 11/21/2022) (1) |
| Nov 14, 2022 | 18 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceutical Holdings, Inc. for Apotex Inc.; Corporate Parent Aposherm Delaware Holdings Corporation for Apotex Corp. filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 11/14/2022) (1) |
| Nov 14, 2022 | 17 | Unopposed Motion to File Under Seal - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) Modified on 11/14/2022 (nms). (Entered: 11/14/2022) (2) |
| Nov 14, 2022 | 16 | [SEALED] DECLARATION of Roshan P. Shrestha, Ph.D re 15 Opening Brief in Support, by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) Modified on 11/14/2022 (nms). (Main Document 16 replaced on 11/18/2022) (nms). (Entered: 11/14/2022) (0) |
| Nov 14, 2022 | 15 | [SEALED] OPENING BRIEF in Support re 14 MOTION to Dismiss Pursuant to F.R.C.P 12(b)(1) and 12(b)(6), filed by Apotex Corp., Apotex Inc..Answering Brief/Response due date per Local Rules is 11/28/2022. (Dorsney, Kenneth) Modified on 11/14/2022 (nms). (Entered: 11/14/2022) (28) |
| Nov 14, 2022 | 14 | MOTION to Dismiss Pursuant to F.R.C.P 12(b)(1) and 12(b)(6) - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) Modified on 11/14/2022 (nms). (Entered: 11/14/2022) (3) |
| Nov 14, 2022 | 13 | STIPULATION and Proposed Order to Extend Time to Answer Complaint - filed by Lupin Limited. (Bilson, David) Modified on 11/14/2022 (nms). (Entered: 11/14/2022) (2) |
| Nov 14, 2022 | 19 | SO ORDERED Granting 17 Unopposed Motion to File Under Seal. Signed by Judge Richard G. Andrews on 11/14/2022. (nms) (Entered: 11/14/2022) (2) |
| Oct 20, 2022 | 12 | STIPULATION TO EXTEND TIME for Lupin to answer, move or otherwise respond to the Complaint (D.I. 1) to November 14, 2022 - filed by Lupin Limited. (Bilson, David) (Entered: 10/20/2022) (2) |
| Sep 30, 2022 | 11 | STIPULATION and [Proposed] Order Extending Time to Respond to Complaint, by Zogenix International Ltd., Zogenix, Inc.. (Dellinger, Megan) Modified on 9/30/2022 (nms). (Entered: 09/30/2022) (2) |
| Sep 30, 2022 | 10 | SUMMONS Returned Executed by Zogenix, Inc., Zogenix International Ltd..Apotex Inc. served on 9/29/2022, answer due 10/20/2022. (Dellinger, Megan) (Entered: 09/30/2022) (2) |
| Sep 30, 2022 | 9 | SUMMONS Returned Executed by Zogenix, Inc., Zogenix International Ltd..Apotex Corp. served on 9/29/2022, answer due 10/20/2022. (Dellinger, Megan) (Entered: 09/30/2022) (2) |
| Sep 30, 2022 | 8 | AFFIDAVIT of Service for Summons, Complaint and related papers served on Lupin Ltd. on September 29, 2022, filed by Zogenix International Ltd., Zogenix, Inc.. (Dellinger, Megan) (Entered: 09/30/2022) (10) |
| Sep 29, 2022 | 7 | MOTION for Pro Hac Vice Appearance of Attorney George F. Pappas, Einar Stole, Thomas J. Sullivan, Tobias Ma, Alexa Hansen, Charles Hall and Jennifer D. Cieluch - filed by Zogenix International Ltd., Zogenix, Inc.. (Dellinger, Megan) (Entered: 09/29/2022) (9) |
| Sep 21, 2022 | 6 | Summons Issued as to Apotex Corp. on 9/21/2022; Apotex Inc. on 9/21/2022; Lupin Limited on 9/21/2022. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(mpb) (Entered: 09/22/2022) (Main Document) (2) |
| Sep 21, 2022 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent UCB SA for Zogenix International Ltd., Zogenix, Inc. filed by Zogenix International Ltd., Zogenix, Inc.. (mpb) (Entered: 09/22/2022) (2) |
| Sep 21, 2022 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,406,606 B2. (mpb) (Entered: 09/22/2022) (1) |
| Sep 21, 2022 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date of Expiration of Patent: 08/05/2037. (mpb) (Entered: 09/22/2022) (1) |
| Sep 21, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 09/22/2022) (3) |
| Sep 21, 2022 | 6 | Summons Issued as to Apotex Corp. on 9/21/2022; Apotex Inc. on 9/21/2022; Lupin Limited on 9/21/2022. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(mpb) (Entered: 09/22/2022) (Summons Issued) (2) |
| Sep 21, 2022 | 6 | Summons Issued as to Apotex Corp. on 9/21/2022; Apotex Inc. on 9/21/2022; Lupin Limited on 9/21/2022. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(mpb) (Entered: 09/22/2022) (Summons Issued) (2) |
| Sep 21, 2022 | 1 | Complaint* (1) |
